Ark Genomic Revolution Etf Price Prediction
| ARKG Etf | USD 23.22 0.14 0.60% |
Oversold Vs Overbought
61
Oversold | Overbought |
Using ARK Genomic hype-based prediction, you can estimate the value of ARK Genomic Revolution from the perspective of ARK Genomic response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ARK Genomic to buy its etf at a price that has no basis in reality. In that case, they are not buying ARK because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell etfs at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ARK Genomic after-hype prediction price | USD 23.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ARK |
ARK Genomic After-Hype Price Prediction Density Analysis
As far as predicting the price of ARK Genomic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ARK Genomic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of ARK Genomic, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ARK Genomic Estimiated After-Hype Price Volatility
In the context of predicting ARK Genomic's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ARK Genomic's historical news coverage. ARK Genomic's after-hype downside and upside margins for the prediction period are 20.95 and 25.49, respectively. We have considered ARK Genomic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ARK Genomic is very steady at this time. Analysis and calculation of next after-hype price of ARK Genomic Revolution is based on 3 months time horizon.
ARK Genomic Etf Price Prediction Analysis
Have you ever been surprised when a price of a ETF such as ARK Genomic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ARK Genomic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ARK Genomic, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 2.27 | 0.03 | 0.00 | 3 Events / Month | 4 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
23.22 | 23.22 | 0.00 |
|
ARK Genomic Hype Timeline
ARK Genomic Revolution is presently traded for 23.22. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of 0.0. ARK is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.21%. %. The volatility of related hype on ARK Genomic is about 17025.0%, with the expected price after the next announcement by competition of 23.22. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out ARK Genomic Basic Forecasting Models to cross-verify your projections.ARK Genomic Related Hype Analysis
Having access to credible news sources related to ARK Genomic's direct competition is more important than ever and may enhance your ability to predict ARK Genomic's future price movements. Getting to know how ARK Genomic's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ARK Genomic may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DIVB | iShares Dividend and | 0.00 | 0 per month | 0.33 | 0.01 | 1.13 | (0.81) | 3.81 | |
| MCSE | Martin Currie Sustainable | (0.03) | 1 per month | 0.00 | (0.25) | 1.44 | (2.08) | 6.65 | |
| MDCP | VictoryShares THB Mid | 0.06 | 1 per month | 0.74 | (0.01) | 1.48 | (1.13) | 3.86 | |
| EV | Mast Global Battery | 0.05 | 10 per month | 1.57 | 0.03 | 3.34 | (2.78) | 7.99 | |
| GK | AdvisorShares Gerber Kawasaki | 0.06 | 5 per month | 1.14 | (0.02) | 1.48 | (1.39) | 5.61 | |
| MJ | Amplify ETF Trust | 0.18 | 2 per month | 0.00 | (0.15) | 3.75 | (3.48) | 25.64 | |
| PP | Tidal ETF Trust | (0.27) | 1 per month | 0.00 | (0.31) | 1.35 | (1.71) | 4.03 | |
| XT | iShares Exponential Technologies | (0.11) | 3 per month | 1.13 | (0.09) | 1.63 | (1.77) | 4.77 | |
| METV | Roundhill Ball Metaverse | (0.06) | 8 per month | 1.00 | 0.02 | 2.02 | (1.61) | 5.12 |
ARK Genomic Additional Predictive Modules
Most predictive techniques to examine ARK price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ARK using various technical indicators. When you analyze ARK charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ARK Genomic Predictive Indicators
The successful prediction of ARK Genomic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ARK Genomic Revolution, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ARK Genomic based on analysis of ARK Genomic hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ARK Genomic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ARK Genomic's related companies.
Story Coverage note for ARK Genomic
The number of cover stories for ARK Genomic depends on current market conditions and ARK Genomic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ARK Genomic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ARK Genomic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out ARK Genomic Basic Forecasting Models to cross-verify your projections. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
The market value of ARK Genomic Revolution is measured differently than its book value, which is the value of ARK that is recorded on the company's balance sheet. Investors also form their own opinion of ARK Genomic's value that differs from its market value or its book value, called intrinsic value, which is ARK Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARK Genomic's market value can be influenced by many factors that don't directly affect ARK Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARK Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARK Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARK Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.